Apr 19 2012
Baby Milk: Nestle favorite Pfizer
Nestle will soon be able to give free rein to its ambitions on the Chinese baby milk market. After several months of a tight battle with its main competitor, Danone, the Swiss have been selected by Pfizer to buy its infant nutrition business, the Wall Street Journal. The agreement could be signed before the end of the month.
The amount of the transaction be around ten billion. "This operation has a real strategic sense for Nestle, said Andrew Wood, analyst at Sanford C. Bernstein, because it deals with good grades and good markets and is performed at a reasonable price. "Nestle has maintained through his status as favorite, because of its financial muscle and posture. He chose to go it alone, while Danone had allied his forces earlier this year with the U.S. Mead Johnson. The French had indicated during February to be interested only in "certain assets, certain brands in some countries," adding that he was not on the verge of acquiring a structuring of the type of Numico in 2008. It might have sinned, according to some experts, by his lack of enthusiasm on this issue. The alliance with Mead Johnson made it more complex to build a competitive offer.
Assets to be sold
Danone, however, could catch up. For competitive reasons, Nestlé will indeed be compelled to give up certain activities, including Mexico, Southeast Asia or South Africa. Danone will then compete with Heinz. The king of ketchup, which carries 11% of its sales with child nutrition, waived bid for the branch of Pfizer, but he is interested in potential sales, particularly in Latin America. Nestlé is about to offer a real nugget, who made last year $ 2.1 billion in sales (+15%). Activity following the acquisition by Pfizer in 2009, the Wyeth for $ 68 billion. Pfizer had announced its intention last summer to focus on the heart of its business. Officially, the pharmaceutical group was still hesitating between an assignment and a split.
Returning to the child nutrition branch of Pfizer, world number five in the sector, with over half of its business in emerging countries, Nestlé could catch up in China. With the SMA brand, Pfizer is already comfortably installed, with 6.7% market share.
Arrived late in the Middle Kingdom, the group of Vevey occupies only the eighth (3.7% market share), behind Abbott. But this market dominated by Mead Johnson, which are born each year 16 million babies, weighs 7 billion. It is set to double by 2015, according to Euromonitor. Number 3 in China, Danone sells more boxes of Dumex baby milk in France. In a rapidly growing market, the cards of infant nutrition are about to be reshuffled in the coming months.
ALSO READ:
"Sweet willing to give up its activities in Brazil
Under cash advance loan facility borrowers are not required to fulfill tedious faxing process.Comments Off
